4.7 Article

Transcriptome-wide Investigation of mRNA/circRNA in miR-184 and Its r.57c > u Mutant Type Treatment of Human Lens Epithelial Cells

期刊

MOLECULAR THERAPY-NUCLEIC ACIDS
卷 7, 期 -, 页码 71-80

出版社

CELL PRESS
DOI: 10.1016/j.omtn.2017.02.008

关键词

-

资金

  1. Fundamental Research Funds for the Central Universities [2016FZA7009]
  2. Zhejiang Provincial Natural Science Foundation of China [LY17H120001]
  3. Key Program of Natural Science Foundation of China [81130018]
  4. Program of National Natural Science Foundation of China [81371001]
  5. Program of National Natural Science Foundation [81428005]
  6. Project of National Clinical Key Discipline of the Chinese Ministry of Health, Zhejiang ProvinceKey Research and Development Program

向作者/读者索取更多资源

m-miR-184 (mutant miR-184, r.57c > u) appears in familial hereditary ocular diseases, including keratoconus, cataracts, EDICT (endothelial dystrophy, iris hypoplasia, congenital cataract, and stromal thinning) syndrome, severe keratoconus, and non-ectatic corneal thinning. The biological function of m-miR-184 in these ocular diseases remains unclear. With the emergence of high-throughput sequencing, it is now possible to discover many different biological components simultaneously. Using two different RNA libraries, we sequenced the complete transcriptome of HLE cells treated with miR-184, m-miR-184, and a negative control. Data were integrated in an effort to identify any novel gene affected by m-miR-184. Notably, we concluded that ALDH5A1 and GABRA3 were disordered by m-miR-184, which might lead to ocular disease. Moreover, circRNA (circular RNA) expression was highy random across miR-184, m-miR-184, and negative control treatment groups. The sequences of the circRNAs did reveal a particularly high level of ALU sequences. In summary, we provide a new avenue for understanding the role of m-miR-184 in ocular diseases.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据